Piperacillin/Tazobactam Qilu

Medicinal product

(Invented) name

Piperacillin/Tazobactam Qilu

Active substance (s)

Piperacilinas/Tazobaktamas

Strength

4 g/0,5 g

Pharmaceutical form

milteliai infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR05, Piperacillin and beta-lactamase inhibitor

Marketing authorisation holder

QILU PHARMA SPAIN S.L., Ispanija

Date of authorisation

2023-05-29

Date of renewal

Documents

5185 Pakuotės lapelis 2025 05 15.docx

5185 Piperacillin_Tazobactam Qilu II PL 2025 05 15.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/7113/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Piperacilinas	4 g
Tazobaktamas	0,5 g

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111043	97154	1097154	flakonas	N1		Receptinis	LT/1/23/5185/001	Netiekiama	-	-	No	-	-
111044	97155	1097155	flakonas	N5		Receptinis	LT/1/23/5185/002	Netiekiama	-	-	No	-	-
111045	97156	1097156	flakonas	N10		Receptinis	LT/1/23/5185/003	Netiekiama	-	-	No	-	-
111046	97157	1097157	flakonas	N12		Receptinis	LT/1/23/5185/004	Netiekiama	-	-	No	-	-
111047	97158	1097158	flakonas	N25		Receptinis	LT/1/23/5185/005	Netiekiama	-	-	No	-	-
111048	97159	1097159	flakonas	N50		Receptinis	LT/1/23/5185/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-05-29	Registruotas